VASCULAR PHARMACEUTICALS, INC.

Profile

Company Names

VASCULAR PHARMACEUTICALS, INC.

Addresses

510 MEADOWMONT VILLAGE CIRCLE, SUITE 283, CHAPEL HILL, NC 27517

903 WALCOTT WAY, CARY, NC 27519

Phone Numbers

919-966-4735
919-345-7933

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$19,121,488.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-12-23 
$3,000,000.00 
$3,000,000.00 
$0.00 
Debt 
2
2013-08-15 
$1,000,000.00 
$1,500,000.00 
$500,000.00 
Debt 
1
2012-09-10 
$15,121,488.00 
$25,121,488.00 
$10,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
CLEMMONS 
EXECUTIVE OFFICER, DIRECTOR
VASCULAR PHARMACEUTICALS, INC.
VAUGHN 
 
KAILIAN 
DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  VALERITAS INC   |  VASCULAR PHARMACEUTICALS, INC.
RICHARD 
 
KENT 
DIRECTOR
CEMPRA HOLDINGS, LLC   |  ALDAGEN INC   |  CSA MEDICAL INC   |  CYTOMEDIX INC   |  ESANEX, INC.   |  CEMPRA, INC.   |  VASCULAR PHARMACEUTICALS, INC.   |  AVISTONE NORTH HIGHLANDS, LLC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  CSA MEDICAL, INC.   |  BARINGS GLOBAL CREDIT FUND (LUX) SCSP, SICAV-SIF   |  BARINGS REAL ESTATE EUROPEAN VALUE ADD FUND II, A SUB-FUND OF BARINGS UMBRELLA FUND (LUX) SCSP SICAV-RAIF   |  BARINGS EUROPEAN REAL ESTATE DEBT INCOME FUND, A SUB-FUND OF BARINGS UMBRELLA FUND (LUX) SCSP SICAV-RAIF   |  AVISTONE TULSA, LLC
BONNIE 
 
LAYMAN 
EXECUTIVE OFFICER
VASCULAR PHARMACEUTICALS, INC.
BENJAMIN 
 
ROVINSKI 
DIRECTOR
AURINIA PHARMACEUTICALS INC.   |  VASCULAR PHARMACEUTICALS, INC.   |  ANTIVA BIOSCIENCES, INC.   |  ANTIOS THERAPEUTICS INC.
RICHARD 
 
SHEA 
EXECUTIVE OFFICER, DIRECTOR
SPIRATION INC   |  CARBON CAPITAL III INC   |  BA SOMETROS MARKET NEUTRAL FUND L.P.   |  YIELDBOT INC.   |  VASCULAR PHARMACEUTICALS, INC.   |  STERIFRE MEDICAL, INC.   |  ADVOCATE CAPITAL ONSHORE ENHANCED BETA FUND, L.P.   |  REDISCOVERY LIFE SCIENCES AKI LLC   |  BASKING BIOSCIENCES, INC.
ELIZABETH 
 
STONER 
DIRECTOR
RADIUS HEALTH, INC.   |  ONCOLOGY INVESTORS OF TEXAS COSTIM, LLC   |  VASCULAR PHARMACEUTICALS, INC.   |  SEMMA THERAPEUTICS, INC.
KEN 
 
WILLIAMS 
DIRECTOR
GIANT NEW MEXICO 4 JOINT VENTURE   |  WESTWOOD ONE INC /DE/   |  VASCULAR PHARMACEUTICALS, INC.   |  DEFENSESTORM, INC.   |  REACTOR EYE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-01-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-23 
2015-02-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-10 
2015-01-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-10 
2013-11-19
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-10 
2013-08-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-08-15 
2012-09-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#